CD8A and neoplasm: Recent studies have shown that immune-related inflammation may mimic tumor progression on ^18F-FDG PET/CT, emphasizing the potential value of immune-specific tracers such as PD-L1 or CD8-targeted PET agents [23,74,75,76].